Upcoming events on IONIS PHARMACEUTICALS, INC. |
|
03/02/21 | | Jahr 2020 Ergebnisveröffentlichung (geplant) |
05/11/21 | | Q1 2021 Ergebnisveröffentlichung (geplant) |
08/10/21 | | Erstes Halbjahr 2021 Ergebnisveröffentlichung (geplant) |
11/10/21 | | Q3 2021 Ergebnisveröffentlichung (geplant) |
|
Past events on IONIS PHARMACEUTICALS, INC. |
|
01/12/21 | 09:40pm | | JP Morgan Healthcare Conference |
12/08/20 | 09:00pm | | BMO Capital Markets Boston Growth Conference |
12/07/20 | 05:00pm | | Investor Day |
12/03/20 | 06:00am | | Piper Sandler Health Care Conference |
|
Upcoming sector events for IONIS PHARMACEUTICALS, INC. |
|
|
|
Past sector events for IONIS PHARMACEUTICALS, INC. |
|
|
|
Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales M $ |
Released Forecast Spread | 284 282 0,74% | 347 286 21% | 508 457 11% | 600 569 5,3% | 1 123 1 029 9,2% | 710
|
Operating income (EBITDA) M $ |
Released Forecast Spread | -68,8 -38,3 -80% | -37,3 -35,8 -4,3% | 75,8 123 -39% | -52,5 -75,0 30% | 378 267 42% | -93,8
|
Operating profit (EBIT) M $ |
Released Forecast Spread | -75,8 -62,6 -21% | -46,3 -92,6 50% | 24,5 45,5 -46% | -61,4 -91,6 33% | 366 286 28% | -111
|
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -87,9 -75,2 -17% | -83,6 -133 37% | -23,3 -30,4 23% | -76,2 -104 27% | 347 281 24% | -105
|
Net income M $ |
Released Forecast Spread | -88,3 -76,6 -15% | -86,6 -128 32% | -5,97 -26,4 77% | 274 -56,3 586% | 294 258 14% | -74,6
|
EPS $ |
Released Forecast Spread | -0,74 -0,66 -13% | -0,72 -1,05 31% | -0,05 -0,09 46% | 2,07 -0,42 598% | 2,08 1,77 17% | -0,51
| Announcement Date | 02/25/2016 | 02/28/2017 | 02/27/2018 | 02/27/2019 | 02/26/2020 | |
|
|
Quarterly results | 2018 Q2 | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) |
Sales M $ |
Released Forecast Spread | 118 130 -9,7% | 145 147 -0,94% | 192 160 20% | 297 285 4,1% | 164 145 13% | 168 152 10% | 494 407 21% | 133 162 -18% | 146 149 -1,9% | 160 182 -12% | 272
| 177
| 181
| 202
| 224
|
Operating income (EBITDA) M $ |
Released Forecast Spread |
|
| 13,4 -36,0 137% | 125 111 12% | -15,3 -32,0 52% | 5,62 -52,0 111% | 264 192 37% | -57,9 -23,6 -145% | -48,1 -55,6 13% | -32,7 -16,4 -99% | 47,0
|
|
|
|
|
Operating profit (EBIT) M $ |
Released Forecast Spread | -50,3 -24,1 -108% | -18,6 -30,0 38% | 10,8 -20,2 153% | 121 104 16% | -19,0 -52,8 64% | 3,00 -52,7 106% | 261 198 32% | -61,0 -31,6 -93% | -52,0 -47,3 -9,9% | -37,0 -25,8 -43% | 39,6
| -23,9
| -17,9
| -11,0
| -17,9
|
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -56,2 -39,0 -44% | -19,9 -43,4 54% | 10,8 -35,9 130% | 121 103 17% | -17,0 -53,6 68% | 4,00 -52,0 108% | 238 190 25% | -62,0 -30,1 -106% | -44,0 -46,3 4,9% | -40,0 -20,0 -100% | 35,5
| -30,5
| -23,8
| -17,8
| -21,4
|
Net income M $ |
Released Forecast Spread | -40,4 -28,6 -41% | -4,56 -27,4 83% | 320 -9,42 3 499% | 84,0 99,0 -15% | -1,00 -38,7 97% | 26,0 -41,2 163% | 184 165 12% | -48,0 -23,4 -106% | -32,0 -33,7 5,2% | -31,0 -10,3 -202% | 37,7
| -24,8
| -16,3
| -11,2
| -15,4
|
EPS $ |
Released Forecast Spread | -0,29 -0,10 -187% | -0,03 -0,17 83% | 2,21 -0,04 5 025% | 0,62 0,74 -16% | -0,01 -0,27 96% | 0,18 -0,30 159% | 1,28 1,00 28% | -0,35 -0,12 -180% | -0,23 -0,26 10% | -0,22 -0,10 -125% | 0,26
| -0,30
| -0,31
| -0,22
| -0,11
| Announcement Date | 08/07/2018 | 11/06/2018 | 02/27/2019 | 05/09/2019 | 08/07/2019 | 11/06/2019 | 02/26/2020 | 05/06/2020 | 08/05/2020 | 11/04/2020 | | | | | |
|
Financial data source © 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|